Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Johnson & Johnson Stock near 52-Week High Amid Executive Sale

Guavy AI Editorial Team
Instruments
JNJ
Share

Johnson & Johnson (US4781601046) stock is trading near its 52-week high of $281.07, despite an executive stock sale and updated earnings expectations that have investors reassessing the healthcare giant's valuation and dividend strength.

According to an insider trading report by Investing.com dated September 4, 2026, Johnson & Johnson executive vice president Timothy Schmid sold approximately $9.2 million in company stock as shares traded close to their recent high.

The same report notes that Johnson & Johnson shares are up 59% over the past year, outperforming many healthcare peers.

More on Stocks

Stocks 7m ago

US Approves $5 Billion Munitions Sale to Saudi Arabia Amid Growing Defense Ties

Stocks 7m ago

QXO Names Ken West as President and COO, Aiming to Improve Operational Discipline

Stocks 7m ago

US Approves $5 Billion Arms Deal for Saudi Arabia

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy